doi: 10.1007/s11695-008-9599-3 224 ZhaoHWangLWeiRXiuDTaoMKeJet al
Cisplatins efficacy in liver cancer is limited by resistance and toxicity, but morin hydrate acts as a potent adjuvant to overcome these barriers
Stefanou MI, Panagiotopoulos E, Tentolouris A, et al
READ NEXT: How do you store semaglutide
Of the dozens under development, Drucker says two have especially high potential to move the needle. The first, called retatrutide, is being developed by the same manufacturer as tirzepatide and would be the first to interact with a third receptor in addition to GLP-1 and GIP
Ital J Neurol Sci 19:363366 Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D (2009) Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease